2,3,7,8-tetrabromodibenzofuran

Suppliers

Names

[ CAS No. ]:
67733-57-7

[ Name ]:
2,3,7,8-tetrabromodibenzofuran

[Synonym ]:
2,3,7,8-tetrabromobenzofuran
2,3,7,8-tetrabromo-dibenzofuran
2,3,7,8-Tetrabrom-dibenzofuran
Dibenzofuran,2,3,7,8-tetrabromo

Chemical & Physical Properties

[ Molecular Formula ]:
C12H4Br4O

[ Molecular Weight ]:
483.77600

[ Exact Mass ]:
479.70000

[ PSA ]:
13.14000

[ LogP ]:
6.63600

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
HP5295170
CHEMICAL NAME :
Dibenzofuran, 2,3,7,8-tetrabromo-
CAS REGISTRY NUMBER :
67733-57-7
BEILSTEIN REFERENCE NO. :
0221403
LAST UPDATED :
199710
DATA ITEMS CITED :
5
MOLECULAR FORMULA :
C12-H4-Br4-O
MOLECULAR WEIGHT :
483.80
WISWESSER LINE NOTATION :
T B656 HOJ DE EE KE LE

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - guinea pig
DOSE/DURATION :
4740 ng/kg
TOXIC EFFECTS :
Nutritional and Gross Metabolic - body temperature decrease
REFERENCE :
ANYAA9 Annals of the New York Academy of Sciences. (New York Academy of Sciences, 2 E. 63rd St., New York, NY 10021) V.1- 1877- Volume(issue)/page/year: 320,151,1979 ** REPRODUCTIVE DATA **
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
4500 ug/kg
SEX/DURATION :
female 10-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death, e.g., stunted fetus) Reproductive - Effects on Embryo or Fetus - fetal death Reproductive - Specific Developmental Abnormalities - craniofacial (including nose and tongue)
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 107,141,1991
TYPE OF TEST :
TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE :
Oral
DOSE :
4500 ug/kg
SEX/DURATION :
female 10-18 day(s) after conception
TOXIC EFFECTS :
Reproductive - Specific Developmental Abnormalities - urogenital system
REFERENCE :
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959- Volume(issue)/page/year: 107,141,1991

Related Compounds

  • 2,3,7,8-TETRAMETHYL-1,4,6,9-THIANTHRENETETRONE
  • 2,3,7,8,12,13,17,18-OCTAETHYL-21H,23H-PORPHINE MANGANESE(III) CHLORIDE
  • 2,3,7,8,12,13,17,18-Octaethyl-21H,23Hporphine ruthenium(II)carbonyl
  • 2,3,7,8-tetramethoxy-10,11-dihydro-5H-10,5-azaethano-dibenzo[a,d]cycloheptene
  • 2,3,7,8-tetramethoxyselenanthrene
  • 2,3,7,8-tetrachlorodibenzo-p-dioxin-1-ol
  • Ethyl 4-azabicyclo[6.1.0]nonane-8-carboxylate
  • tert-butyl N-[(2,4-dihydroxyphenyl)methyl]carbamate
  • 4-methoxy-N,N-dimethyl-5-(piperidin-4-yl)-1,3-thiazol-2-amine
  • Methyl 3-amino-3-(4-nitrophenyl)butanoate
  • 2-Amino-5-(dimethylamino)-3-hydroxypentanoic acid
  • 1-{Imidazo[1,2-a]pyridin-3-yl}ethane-1,2-diol
  • 6-Acetamido-2,3-difluorobenzoic acid
  • 1,3-dioxo-2,3-dihydro-1H-isoindol-2-yl 3,4-diphenylbutanoate
  • benzyl N-(prop-2-en-1-yl)-N-(1,2,3,4-thiatriazol-5-yl)carbamate
  • Thalidomide-5'-C3-PEG1-OH
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.